Exercise Rebuilds Muscle Capillaries—but Not Yet Stem Cells

Exercise can rebuild capillaries in aging muscle. That matters because capillaries do more than deliver oxygen: they help form the neighborhood around each muscle fiber, where muscle stem cells and other repair-related cells live. But the leap from "more capillaries" to "reactivated muscle stem cells" outruns the human evidence.

The best direct resistance-training trial found more capillaries per fiber, remodeling of fibro-adipogenic progenitor cells, and larger type II fibers after 10 weeks. It found no change in muscle stem cell content. A separate trial in healthy older adults found that greater capillarization did not improve microvascular perfusion or add to later hypertrophy. The vascular remodeling is real; the proposed stem-cell payoff remains unproven.

Capillary loss may contribute to muscle aging

Age-related muscle loss, or sarcopenia, has many causes: reduced activity, illness, nutrition, neural changes, inflammation, and altered hormone signaling all matter. Capillary rarefaction—fewer capillaries within muscle—may be one contributor.

A 2025 systematic review by Ding et al. examined 21 studies in adults aged 55 to 82. The review concluded that aerobic, resistance, and combined training can each improve skeletal-muscle capillarization. It also discussed evidence suggesting that capillary loss can precede measurable muscle atrophy, including observations in systemic sclerosis. That observation supports an upstream role, but it does not prove that capillary loss causes sarcopenia in otherwise healthy older adults.

The review could not pool the results into a meta-analysis because the studies differed too much in participants, training approaches, and capillary measurements. It therefore offers a credible map of the field, not a single effect size that tells you how many capillaries a given program will add.

What resistance training changed—and what it did not

The most useful human test of this idea came from Binet et al.'s 2023 randomized trial. Twenty-seven middle-aged adults, ages 40 to 64, completed 10 weeks of progressive whole-body resistance training. The researchers analyzed muscle biopsies before and after training, including CD31+ capillaries per fiber, muscle stem cells (MuSCs), and fibro-adipogenic progenitors (FAPs).

Training increased CD31+ capillaries per fiber (P<0.05) and increased type II fiber cross-sectional area (P=0.014). These are structural changes in the muscle tissue, not merely better performance on a strength test. The trial also found a marked rise in PDGFRα+/CD90+ FAPs (P<0.0001) and a decline in PDGFRα+/CD90− FAPs (P=0.044).

FAPs are resident cells that help organize muscle repair and remodeling. They can support regeneration, but their behavior depends on context; a shift in a cell subtype is not a direct measure of better long-term muscle function. In this trial, the FAP changes occurred alongside fiber growth, but the study did not establish that the capillary increase caused the FAP shift, or that either change caused hypertrophy.

The key constraint is simple: MuSC content did not change after the 10-week program. If added capillaries rapidly restored a dormant human stem-cell pool, this is where the signal should have appeared. It did not. That null result does not prove that longer training cannot affect MuSC biology, nor does a cell count capture every possible change in stem-cell behavior. It does show that increased capillarization, FAP remodeling, and larger type II fibers can occur without an increase in measured MuSC content over 10 weeks.

More capillaries did not improve perfusion or hypertrophy

A 2025 randomized trial by Betz et al. tested an even more practical version of the vascular theory in healthy older adults. Participants completed aerobic exercise preconditioning before a subsequent resistance-training block. Aerobic training increased muscle-fiber capillarization, yet it did not increase microvascular perfusion and did not augment resistance-training-induced hypertrophy.

That result separates anatomy from function. A higher capillary count is a structural endpoint; perfusion measures blood flow through the tissue. Neither measurement, by itself, demonstrates improved stem-cell signaling. The trial does not mean capillaries are irrelevant. Its aerobic protocol may not have been the best way to prime muscle for later growth. It does mean that more visible vascular structure cannot be treated as a guaranteed route to better blood flow, more muscle, or a rejuvenated stem-cell niche.

Capillarization is a plausible part of healthy muscle remodeling. It is not a validated shortcut to stem-cell activation in humans.

Does sex change the cellular response?

Binet et al. included 13 men and 14 women and reported no statistically significant sex differences in capillarization, FAP subpopulations, MuSC content, or fiber hypertrophy after training. That is useful, but it is not proof that men and women receive identical cellular effects. A total sample of 27 is too small to rule out many sex-specific differences, especially in biopsy-based outcomes that vary substantially between individuals.

The pattern is similarly mixed in a 2024 12-week concurrent-training trial by Sterczala et al. in recreationally active men and women. The study reported broadly similar structural and cellular adaptations across sexes, while the supplied results also note type I and type IIa fiber hypertrophy in men. These findings cannot settle a broad sex-equivalence claim because the trial was not designed with enough precision for definitive sex-stratified cellular comparisons.

Biology gives researchers a reason to keep asking. In a 20-week trial of prostate-cancer patients starting androgen-deprivation therapy, Overkamp et al. found that resistance exercise counteracted treatment-related suppression of muscle fiber characteristics. The usual-care group showed declines in type I and type II fiber size, while the intervention addressed this adverse muscle environment. This is not a female-versus-male capillarity study, but it shows that hormone milieu can change how muscle responds to training.

Context can blunt the angiogenic response

Metabolic health may also shape vascular adaptation. In an acute-exercise study, Garner et al. found that obesity altered pro- and anti-angiogenic signaling patterns consistent with inadequate compensatory angiogenesis after resistance exercise. The study involved an acute bout, not a long training program, and it did not measure MuSCs or FAPs. It cannot explain aging muscle directly, but it warns against assuming that every muscle responds to loading with the same vascular signals.

What training can reasonably promise

Progressive resistance training remains the practical foundation. In adults 65 and older, a 2024 meta-analysis of 28 randomized trials found significant improvements in muscle size (standardized mean difference 0.34, 95% CI 0.16 to 0.52) and fiber area (SMD 0.54, 95% CI 0.24 to 0.84). Those are training outcomes with direct relevance to maintaining muscle, even though the studies did not establish that capillarization caused the gains.

For older adults who need help preserving or gaining lean mass, nutrition can matter too. A six-month placebo-controlled trial in 122 healthy adults ages 60 to 84 found that daily 10 g milk-protein supplementation during low-to-moderate-intensity exercise increased lean body mass by 0.54 kg (P<0.001); the isocaloric placebo group changed by −0.10 kg (P=0.534). This does not test capillary biology, but it reinforces a less glamorous point: muscle adaptation needs training and adequate building material.

Lift progressively and consistently. Add aerobic work if it improves your fitness, health, or enjoyment. Expect muscle to remodel in useful ways, including its vascular architecture. Do not buy a program on the promise that it will "wake up" muscle stem cells in 10 weeks. Human trials have not shown that result.